Lifeforce Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Notable Labsnotablelabs.comin𝕏Series A · Sep 2017 · $10M
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
BiotechHealthtechMedical DevicesSan Francisco, US
Matthew De Silva(Founder/CEO)inPete Quinzio(Founder)in
Co-investors11.2 CapitalBuilders VCFundersClubHemisphere Ventures LLCY CombinatorAmplify Partners+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.